{"id":"https://openalex.org/W2987862816","doi":"https://doi.org/10.1182/blood.v110.11.743.743","title":"High Level Phosphatase Activity Revealed in Chronic Lymphocytic Leukemia Cells That Use Mutated Immunoglobulin Heavy Chain Variable Region Genes and Lack High-Level Expression of the Zeta-Associated Protein 70 (ZAP-70).","display_name":"High Level Phosphatase Activity Revealed in Chronic Lymphocytic Leukemia Cells That Use Mutated Immunoglobulin Heavy Chain Variable Region Genes and Lack High-Level Expression of the Zeta-Associated Protein 70 (ZAP-70).","publication_year":2007,"publication_date":"2007-11-16","ids":{"openalex":"https://openalex.org/W2987862816","doi":"https://doi.org/10.1182/blood.v110.11.743.743","mag":"2987862816"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v110.11.743.743","doi":"https://doi.org/10.1182/blood.v110.11.743.743","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v110.11.743.743","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071972147","display_name":"Wendy J. Fantl","orcid":"https://orcid.org/0000-0003-3452-7292","observed_orcids":["https://orcid.org/0000-0003-3452-7292"]},"institutions":[{"id":"https://openalex.org/I4210150403","display_name":"Nodality (United States)","ror":"https://ror.org/04b85bq70","country_code":"US","type":"company","lineage":["https://openalex.org/I4210150403"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Wendy J. Fantl","raw_affiliation_strings":["Nodality Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nodality Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I4210150403"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053928335","display_name":"Rolla Yafawi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150403","display_name":"Nodality (United States)","ror":"https://ror.org/04b85bq70","country_code":"US","type":"company","lineage":["https://openalex.org/I4210150403"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rolla L. Yafawi","raw_affiliation_strings":["Nodality Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nodality Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I4210150403"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110947280","display_name":"Santosh Putta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150403","display_name":"Nodality (United States)","ror":"https://ror.org/04b85bq70","country_code":"US","type":"company","lineage":["https://openalex.org/I4210150403"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Santosh K. Putta","raw_affiliation_strings":["Nodality Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nodality Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I4210150403"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049102607","display_name":"Ying-Wen Huang","orcid":"https://orcid.org/0000-0003-3727-7903","observed_orcids":["https://orcid.org/0000-0003-3727-7903"]},"institutions":[{"id":"https://openalex.org/I4210150403","display_name":"Nodality (United States)","ror":"https://ror.org/04b85bq70","country_code":"US","type":"company","lineage":["https://openalex.org/I4210150403"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ying-Wen Huang","raw_affiliation_strings":["Nodality Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nodality Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I4210150403"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043351910","display_name":"Helen Francis-Lang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150403","display_name":"Nodality (United States)","ror":"https://ror.org/04b85bq70","country_code":"US","type":"company","lineage":["https://openalex.org/I4210150403"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Helen L. Francis-Lang","raw_affiliation_strings":["Nodality Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nodality Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I4210150403"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010336471","display_name":"Laura Z. Rassenti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rassenti Z. Laura","raw_affiliation_strings":["Dept. of Medicine, UCSD, Moores Cancer Center, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept. of Medicine, UCSD, Moores Cancer Center, San Diego, CA, USA","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109130680","display_name":"Aileen Cleary Cohen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150403","display_name":"Nodality (United States)","ror":"https://ror.org/04b85bq70","country_code":"US","type":"company","lineage":["https://openalex.org/I4210150403"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aileen Cleary Cohen","raw_affiliation_strings":["Nodality Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nodality Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I4210150403"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036828560","display_name":"Thomas J. Kipps","orcid":"https://orcid.org/0000-0002-0064-4549","observed_orcids":["https://orcid.org/0000-0002-0064-4549"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas J. Kipps","raw_affiliation_strings":["Dept. of Medicine, UCSD, Moores Cancer Center, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept. of Medicine, UCSD, Moores Cancer Center, San Diego, CA, USA","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5043351910","https://openalex.org/A5049102607","https://openalex.org/A5071972147","https://openalex.org/A5110947280"],"corresponding_institution_ids":["https://openalex.org/I4210150403"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.43310553,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"110","issue":"11","first_page":"743","last_page":"743"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/b-cell-receptor-signaling","display_name":"B cell receptor signaling","score":0.9890000224113464},{"id":"https://openalex.org/keywords/phosphatase","display_name":"phosphatase","score":0.7540000081062317},{"id":"https://openalex.org/keywords/zap-70","display_name":"ZAP-70","score":0.8429999947547913},{"id":"https://openalex.org/keywords/syk-phosphorylation","display_name":"Syk phosphorylation","score":0.6629999876022339},{"id":"https://openalex.org/keywords/hydrogen-peroxide","display_name":"hydrogen peroxide","score":0.6309999823570251},{"id":"https://openalex.org/keywords/ship1","display_name":"SHIP1","score":0.6000000238418579},{"id":"https://openalex.org/keywords/shp-1","display_name":"SHP-1","score":0.9120000004768372},{"id":"https://openalex.org/keywords/shp2","display_name":"SHP2","score":0.9990000128746033},{"id":"https://openalex.org/keywords/unmutated-igvh","display_name":"unmutated IgVH","score":0.7789999842643738}],"concepts":[{"id":"https://openalex.org/C43907098","wikidata":"https://www.wikidata.org/wiki/Q903924","display_name":"breakpoint cluster region","level":3,"score":0.7256596088409424},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.666461169719696},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5708902478218079},{"id":"https://openalex.org/C157695867","wikidata":"https://www.wikidata.org/wiki/Q1100474","display_name":"B-cell receptor","level":4,"score":0.5277695655822754},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.4936710298061371},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.46477892994880676},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.46422263979911804},{"id":"https://openalex.org/C85528070","wikidata":"https://www.wikidata.org/wiki/Q643602","display_name":"Protein tyrosine phosphatase","level":3,"score":0.44745558500289917},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.43749725818634033},{"id":"https://openalex.org/C36394416","wikidata":"https://www.wikidata.org/wiki/Q949267","display_name":"Immunoglobulin light chain","level":3,"score":0.41890397667884827},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.41534411907196045},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3195992112159729},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.3099110722541809},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.24809181690216064},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.19906491041183472},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1379709541797638}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v110.11.743.743","doi":"https://doi.org/10.1182/blood.v110.11.743.743","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v110.11.743.743","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1999377479","https://openalex.org/W2033315156","https://openalex.org/W2588827997","https://openalex.org/W2557428107","https://openalex.org/W2526018104","https://openalex.org/W1984046622","https://openalex.org/W7097378567","https://openalex.org/W4389248100","https://openalex.org/W2988896759","https://openalex.org/W2979839741"],"abstract_inverted_index":{"Abstract":[0],"Signals":[1],"propagated":[2],"through":[3],"the":[4,10,21,38,99,286,339,377],"B":[5,15,114,293],"cell":[6,115],"receptor":[7],"(BCR)":[8],"guide":[9],"maturation":[11],"and":[12,17,23,57,92,234,248,272,331],"survival":[13],"of":[14,25,60,70,133,212,225,239,243,251,269,275,288,291,308,334,354,371,376,403],"cells":[16,34,122,168,214,258,294,326,345,363,394],"might":[18],"factor":[19],"in":[20,32,110,120,131,164,193,285,306,324,343,361],"pathogenesis":[22],"progression":[24],"chronic":[26],"lymphocytic":[27],"leukemia":[28,393],"(CLL).":[29],"BCR":[30,100,162,181,191],"signaling":[31,72,83,119,182,192,312,341],"CLL":[33,74,121,165,167,213,325,362],"was":[35,47,108,358],"investigated":[36],"at":[37,85,98],"single-cell":[39],"level":[40,237,353],"using":[41,49],"multiparametric":[42],"flow":[43,373],"cytometry.":[44],"Concurrent":[45],"analysis":[46],"performed":[48],"fluorochrome-conjugated":[50],"antibodies":[51,61],"specific":[52,63],"for":[53,126,138,385],"B-cell":[54],"surface":[55,252,347],"antigens":[56],"a":[58,67,105,111,129,134,175,235,303,317,386],"panel":[59],"recognizing":[62],"phospho-peptide":[64],"epitopes":[65],"within":[66],"selected":[68],"group":[69],"intracellular":[71,311],"proteins.":[73,313],"samples":[75,405],"from":[76,295,395],"patients":[77,396],"(N=6)":[78],"showed":[79],"weak":[80],"or":[81,140,152,160],"minimal":[82],"activity":[84,323,357],"p72SYK/p70ZAP,":[86,245],"Erk1/2,":[87],"B-Cell":[88],"linker":[89],"protein":[90,136],"(BLNK)":[91],"phospholipase-C\u03b3-2,":[93],"(PLC\u03b32)":[94],"when":[95],"stimulated":[96],"only":[97],"with":[101,171,220,264,368,389,397],"anti-\u03bc":[102],"crosslinking,":[103],"whereas":[104],"robust":[106],"signal":[107],"observed":[109,342,360],"control":[112],"Ramos":[113],"line.":[116],"The":[117],"low-level":[118],"could":[123,383],"be":[124],"accounted":[125],"by":[127,141,145,381],"either":[128],"defect":[130],"activation":[132,163],"key":[135],"required":[137],"signaling,":[139],"enhanced":[142],"inhibition":[143],"mediated":[144],"phosphatases":[146,157],"such":[147],"as":[148],"SHIP-1,":[149],"SHIP-2,":[150],"SHP-1,":[151],"SHP-2.":[153],"To":[154],"determine":[155],"whether":[156],"were":[158,169,277],"preventing":[159],"dampening":[161],"samples,":[166],"treated":[170],"hydrogen":[172],"peroxide":[173],"(H2O2),":[174],"physiologic":[176],"phosphatase":[177,322,356],"inhibitor":[178],"generated":[179],"during":[180],"that":[183,215,259,327,364],"has":[184],"been":[185],"used":[186],"previously":[187,318],"to":[188,281,298,301,338,391,408],"reveal":[189,316],"dysregulated":[190],"follicular":[194],"lymphoma":[195],"(Sing":[196],"et":[197,206],"al.,":[198,207],"Cell":[199],"2005,":[200],"Reth.,":[201],"Nat.":[202],"Immunol.":[203],"2002,":[204],"Irish":[205],"Blood":[208],"2006).":[209],"H2O2":[210,299,382],"treatment":[211],"had":[216,260],"molecular":[217,261],"features":[218,262],"associated":[219,263],"indolent":[221,398],"disease":[222,267],"(e.g.":[223],"use":[224],"mutated":[226,329],"immunoglobulin":[227],"heavy":[228],"chain":[229],"variable":[230],"region":[231],"genes":[232],"(IgVH)":[233],"low":[236,332],"expression":[238,274,370],"ZAP70)":[240],"induced":[241],"high-levels":[242],"phosphorylated":[244],"ERK1/2,":[246],"BLNK,":[247],"PLC\u03b32,":[249],"independent":[250],"F(ab)2anti-\u03bc":[253],"ligation.":[254,349],"In":[255],"contrast,":[256],"CLL-B":[257],"more":[265],"aggressive":[266,400],"(expression":[268],"unmutated":[270,366],"IgVH":[271,330,367],"high-level":[273,321,369],"ZAP-70)":[276],"significantly":[278],"less":[279],"responsive":[280],"this":[282,351,410],"treatment,":[283],"even":[284],"presence":[287],"F(ab)2anti-\u03bc.":[289],"Exposure":[290],"blood":[292],"healthy":[296],"donors":[297],"failed":[300],"elicit":[302],"substantial":[304],"increase":[305],"phosphorylation":[307,379],"these":[309,344],"same":[310],"These":[314],"studies":[315],"unrecognized,":[319],"constitutive":[320,355],"express":[328,365],"levels":[333],"ZAP-70,":[335],"possibly":[336],"contributing":[337],"attenuated":[340],"following":[346],"IgM":[348],"Because":[350],"high":[352],"not":[359],"ZAP70,":[372],"cytometric":[374],"measurement":[375],"increased":[378],"triggered":[380],"provide":[384],"useful":[387],"means":[388],"which":[390],"distinguish":[392],"versus":[399],"CLL.":[401],"Evaluation":[402],"additional":[404],"is":[406],"ongoing":[407],"test":[409],"hypothesis.":[411]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-11-22T00:00:00"}